The United States Cancer Treatment Drugs Market serves as the primary revenue engine for the region, propelled by high healthcare expenditure, major academic medical networks, and strong domestic presence of leading global pharmaceutical companies. Market expansion across the nation is supported by streamlined U.S. FDA accelerated approval pathways and Breakthrough Therapy designations that...